T cells enhance stem-like properties and conditional malignancy in gliomas

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Irvin, Dwain K ^a   Jouanneau, Emmanuel ^a,b   Duvall, Gretchen ^a   Zhang, Xiao xue ^a   Zhai, Yuying ^a   Sarayba, Danielle ^a   Seksenyan, Akop ^a   Panwar, Akanksha ^a   Black, Keith L ^a   Wheeler, Christopher J ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYCLOPAMINE; DENDRITIC CELL VACCINE; RNA; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CANCER GRADING; CANCER STEM CELL; CANCER TISSUE; CARCINOGENICITY; CELL DIFFERENTIATION; CELL HETEROGENEITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TUMOR IMMUNITY; WILD TYPE; ANIMAL; BRAIN TUMOR; C57BL MOUSE; CANCER TRANSPLANTATION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DNA MICROARRAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GLIOMA; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION;

MURINAE;

ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; DNA PRIMERS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77956217454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010974     Document Type: Article

References (45)

1. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432.
2. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
3. Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353: 811-822.
4. Piccirillo SGM, Reynolds BA, Zanetti N, Lamorte G, Binda E, et al. (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human bran tumour-initiating cells. Nature 444: 761-765.
5. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang W-C, et al. (2006) Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444: 1083-1087.
6. Ruiz I, Altaba A, Stecca B, Sanchez P (2004) Hedgehog-Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer. Cancer Lett 204: 145-157.
7. Sanchez P, Ruiz I, Altaba A (2005) In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice. Mech Dev 122: 223-230.
8. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz I, et al. (2006) HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity. Curr Biol 17: 165-172.
9. Lee J, Son MJ, Woolard K, Donin NM, Li A, et al. (2008) Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13: 69-80.
10. Oliver TG, Wechsler-Reya RJ (2004) Getting at the Root and Stem of Brain Tumors. Neuron 42: 885-888.
11. CBTRUS (2004-2005) Central Brain Tumor Registry of the United States.
12. Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, et al. (2009) Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg 111: 478-487.
13. Souweidane MM, Morgenstern PF, Christos PJ, Edgar MA, Khakoo Y, et al. (2009) Intraoperative arachnoid and cerebrospinal fluid sampling in children with posterior fossa brain tumors. Neurosurgery 65: 72-78.
14. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
15. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, et al. (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5
16. Stupp R, Hegi ME (2003) Recent developments in the management of malignant glioma. J Clin Oncol 1091-9118: 779-788.
17. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, et al. (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20: 1375-1382.
18. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, et al. (2008) Identification of cells initiating human melanomas. Nature 451: 345-349.
19. Xu Q, Yuan X, Liu G, Black KL, Yu JS (2008) Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas. Stem Cells 26: 3018-3026.
20. Calzascia T, Masson F, Di Berardino-Besson W, Contassot E, Wilmotte R, et al. (2005) Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. Immunity 22: 175-184.
21. Masson F, Calzascia T, Di Berardino-Besson W, de Tribolet N, Dietrich PY, et al. (2007) Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells. J Immunol 179: 845-853.
22. Yu JS, Liu G, Ying H, Yong WH, Black KL, et al. (2004) Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific cytotoxic T cells in patients with malignant glioma. Cancer Res 64: 4973-4979.
23. Wheeler CJ, Black KL, Liu G, Mazer M, Zhang X-X, et al. (2008) Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients. Cancer Res 68: 5955-5964.
24. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, et al. (2003) Gene expression profiling identifes molecular subtypes of gliomas. Oncogene 22: 4918-4923.
25. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: Epub 2002 Jun 2018.
26. Prins RM, Incardona F, Lau R, Lee P, Claus S, et al. (2004) Characterization of defective CD4-CD8-T cells in murine tumors generated independent of antigen specificity. J Immunol 172: 1602-1611.
27. Prins RM, Odesa SK, Liau LM (2003) Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model. Cancer Res 63: 8487-8491.
28. Jouanneau E, Poujol D, Gulia S, Le Mercier I, Blay JY, et al. (2006) Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model. Cancer Immunol Immunother 55: 254-267.
29. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, et al. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015.
30. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, et al. (2005) Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65: 2353-2363.
31. Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, et al. (2006) PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51: 187-199.
32. Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, et al. (2007) Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 106: 417-427.
33. Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, et al. (2007) Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25: 2524-2533.
34. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, et al. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
35. Mao Y, Zhou L, Zhu W, Wang X, Yang G, et al. (2007) Proliferative status of tumor stem cells may be correlated with malignancy grade of human astrocytomas. Front Biosci 12: 2252-2259.
36. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, et al. (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848.
37. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
38. Minami M, Nariuchi H, Kawasaki H, Dorf M (1986) The role of class II MHC molecules in the activation of class I-reactive T cell hybridomas. J Immunol 136: 3341.
39. Schneck J, Maloy WL, Coligan JE, Margulies DH (1989) Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell 56
40. Wheeler CJ, von Hoegen P, Parnes JR (1992) An immunological role for the CD8 beta-chain. Nature 357: 247-249.
41. Wheeler CJ, Chen J-Y, Potter TA, Parnes JR (1998) Mechanisms of CD8b-mediated T cell response enhancement: Interaction with MHC class I/b2-microglobulin and functional coupling to TCR/CD3. J Immunol 160: 4199-4207.
42. Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, et al. (2006) Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66: 10247-10252.
43. Xu Q, Liu G, Yuan X, Xu M, Wang H, et al. (2009) Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 27: 1734-1740.
44. Liu G, Akasaki Y, Khong HT, Wheeler CJ, Das A, et al. (2005) Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy. Oncogene 24: 5226-5234.
45. Jiao Z, Zhang ZG, Hornyak TJ, Hozeska A, Zhang RL, et al. (2006) Dopachrome tautomerase (Dct) regulates neural progenitor cell proliferation. Dev Biol 296: 396-408.